Status:
COMPLETED
A Pilot Study of the Use of Magnetic Seizure Therapy for Depression
Lead Sponsor:
Bayside Health
Conditions:
Treatment Resistant Depression
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
Brief Summary
Electro convulsive therapy (ECT) remains the only established therapy for the large percentage of patients with depression who fail to respond to standard treatments. It is commonly used but has subst...
Eligibility Criteria
Inclusion
- Have a DSM-IV diagnosis of a major depressive episode
- Are referred for or an outpatient course of ECT at the Alfred Hospital
- Age 18-75
- Have a Montgomery-Asberg Depression Rating Scale (MADRS) score of \> 25 (moderate - severe depression)
- Demonstration of capacity to give informed consent: this will be assessed by the study psychiatrist as well as the patient's primary treating psychiatrist.
Exclusion
- Have an unstable medical condition, or neurological disorder or are currently pregnant or lactating.
- Patients not considered sufficiently well to undergo general anaesthesia for any reason
- Patients with cardiac pacemakers, cochlear implants or other implanted electronic devices. Patients with non-electric metallic implants will also be excluded.
- Significant concurrent axis 1 or 11 psychiatric comorbidity.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00808938
Start Date
January 1 2009
End Date
January 1 2011
Last Update
February 13 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alfred Psychiatry Research Centre
Prahran, Victoria, Australia, 3181